Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021
(in cartons)
Characteristic
For first dose
For second dose
Supplementary supply*
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
You need a ÌÇÐÄÆƽâ°æ Account for unlimited access
*According to the source, 1,000 cartons should be enough to administer first and second doses of COVID-19 vaccinations to the remaining number of medical professionals and complete vaccinations for all health professionals.
A carton includes 195 vials, which equates to 975 doses (five doses per one vial) or 1,170 doses (six doses per one vial).
Citation formats
Supply of Pfizer COVID-19 vaccination for medical professionals Japan 2021
As of May 3, 2021, a total of *** thousand cartons of coronavirus disease (COVID-19) vaccination developed by Pfizer Inc. and BioNTech SE were planned to be supplied to medical professionals in Japan. The distribution of Pfizer-BioNTech COVID-19 vaccinations for approximately *** million health professionals was to be completed with the last one thousand cartons of supplementary supply in the week of May 10 to **, 2021.
The supply of COVID-19 vaccination in Japan has begun on February 17, 2021, mainly for health professionals. On April 12, 2021, the government started the vaccine administration for citizens aged 65 and older.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
MHLW (Japan). (May 3, 2021). Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). "Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons)." Chart. May 3, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). (2021). Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). "Planned Supply Number of Coronavirus Disease (Covid-19) Vaccine for Medical Professionals Developed by Pfizer-biontech in Japan as of May 3, 2021 (in Cartons)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 3 May 2021, /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan), Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) ÌÇÐÄÆƽâ°æ, /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/ (last visited August 01, 2026)
Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph], MHLW (Japan), May 3, 2021. [Online]. Available: /statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
